Indefinite Delivery Contract SPE2DR25D2205

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC will serve as the primary vehicle for the DLA to procure brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and other critical medical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp valued at $999,999,999 through November 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC has a 30-month base period and three 30-month option periods, running through December 2026. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the provision of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for DLA to procure a comprehensive range of medical commodities, including...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, which runs through December 2036, will serve as the primary vehicle for procuring specialty medications, brand-name and generic drugs, vaccines,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp. to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC, which runs through December 2036, serves as a prime vehicle for delivering critical medical commodities including specialty medications, brand-name and generic drugs,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC has a period of performance from September 2025 to December 2036 and serves as a primary vehicle for the DLA to procure critical medical commodities, including...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period with three 30-month option periods, for a total potential period of performance through December 2036. The IDC aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical and medical supply support. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion across all awarded regions. This IDC serves as the primary vehicle for supplying a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical and medical supply products to support military healthcare programs globally. The IDC has a period of performance through December 2036 and serves as a prime contracting vehicle for the DLA to procure essential medical commodities including specialty medications,...

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally.

The IDC, which has a 30-month base period and three 30-month option periods, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to deliver brand-name, generic, and specialty medications, as well as associated medical commodities such as syringes, vials, and test kits, to support normal day-to-day operations and contingency requirements for the Department of Defense, United States Coast Guard, and other designated federal agencies and healthcare programs. The contract does not have any set-aside requirements and will be awarded on a Lowest Price Technically Acceptable basis, potentially utilizing a reverse auction strategy to obtain the best distribution fees. The procurement is an unrestricted, fully competitive acquisition covering a wide range of therapeutic areas to ensure resiliency and access to vital pharmaceuticals.

Generated 6/6/25, 10:12 AM